Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Egea Biosciences

2000 FOUNDED
M&A STATUS
31-40 EMPLOYEES
M&A LATEST DEAL TYPE
Description

Developer of protein drugs. The company's technology platform creates large libraries of proteins with directed single amino acid changes based on any imagined structure as programmed in a computer in order to revolutionize protein drug development and optimization.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 6759 Mesa Ridge Road
  • Suite 100
  • San Diego, CA 92121
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Egea Biosciences’s full profile, request a free trial.

Egea Biosciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 18-May-2004 Completed Startup
5. Grant 16-Jan-2004 00000 Completed Startup
4. Grant 31-May-2003 00000 Completed Startup
3. Grant 31-Jan-2002 00000 Completed Startup
2. Grant 28-Dec-2000 $317K Completed Startup
1. Early Stage VC 01-Jan-2000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Egea Biosciences Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Hamilton BioVentures Venture Capital Minority 000 0000 000000 0
United States Army Government 000 0000 000000 0